Generex- Update on the IND for the SARS Covid Ii-Key Peptide Vaccine. No excuses. Bring it, tell it. Good or bad. Investors relish honesty. We would hold firm on difficulty. Stop the bleeding from nothing. Let’s be sophisticated. Good night.
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links